WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck & Co., Inc. (NYSE:MRK) today announced the appointment of Dr. Michael Rosenblatt as Executive Vice President and Chief Medical Officer, effective immediately. Dr. Rosenblatt will be Merck’s primary voice to the global medical community and will speak to critical issues such as patient safety.
